October
Bayer seeks ACS approval for Xarelto
Bayer has said it intends to file Xarelto (rivaroxaban) for marketing approval in the treatment of patients with acute coronary syndrome (ACS)
03 Oct 2011
Takeda buys Nycomed and names CEO
Takeda has completed the purchase of Switzerland-based pharmaceutical firm Nycomed and named Dr Frank Morich as Nycomed's CEO
03 Oct 2011
GSK looks to invest $2bn in India
Andrew Witty, CEO of GlaxoSmithKline, has said the company is looking to make significant investments in India as part of the company's plan to increase its presence in emerging markets
03 Oct 2011
Alpha-Plus integrates into Fishawack
Alpha-Plus Medical Communications, a member of the Fishawack Group of Companies, has fully integrated into Fishawack Communications.
03 Oct 2011
New agency launch: Cuttsy and Cuttsy
An independent marketing and communications agency, Cuttsy and Cuttsy has been launched by directors Mathew Cutts and Caroline Benson.
03 Oct 2011
New appointments for Interlace Global Group
Interlace Global Group has appointed Daniel Gibbs and Reghu Venkatesan as new business unit heads for its two global London-based companies.
03 Oct 2011
Hikma buys majority in Promopharm
Hikma Pharmaceuticals has acquired 63.9 per cent of Morocco-based company, Promopharm, for $111.2m with further plans for a full acquisition
04 Oct 2011
Merck/Ono collaborate on MS and cancer
Merck Serono and Ono Pharmaceutical are to work together to develop and market new treatments for both multiple sclerosis and cancer
04 Oct 2011
MSD wins Fosamax case
A US federal court has ruled in favour of MSD after a woman took the pharmaceutical company to trial based on dental problems she blamed on osteoporosis treatment Fosamax
04 Oct 2011
Bayer plans expansion in Japan
Bayer has said it plans to grow at an average of six per cent per year in Japan over the next five years, with the pharmaceutical firm expecting annual revenue of €2.4bn in the country by 2015
05 Oct 2011